This opportunity is no longer accepting applications.
grant RFA-DA-25-068

Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)

This grant opportunity aims to support research into how inflammasomes (protein complexes involved in immune response) affect brain health in cases of drug exposure and HIV infection. It seeks to discover how these inflammasomes are involved in virus and drug-induced immune responses, aiming to identify molecular markers and immune cells in the brain that are linked to HIV-1 in people who use …

The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activ…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Awards & funding

Award Ceiling: $500,000
Award Amount: $500,000

Dates

Opportunity Released: October 29, 2024
Open for Submission: October 29, 2024
Submission Deadline: March 13, 2025
Application Window Closes: March 13, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.